Jafron Biomedical News

Jafron Biomedical: An indicative announcement on the resumption of stock conversion for Jianfan Bonds

May 29 11:00

Jafron Biomedical: 2023 Equity Distribution Implementation Notice

May 23 11:00

Jafron Biomedical: Announcement on the adjustment of Jianfan's debt-for-equity conversion price due to equity allocation

May 23 11:00

Jafron Biomedical: An indicative announcement on the suspension of share conversion of Jianfan Bonds during the implementation of equity distribution

May 22 07:34

Jafron Biomedical: Capital Reduction Announcement on Repurchase and Cancellation of Some Restricted Shares

May 20 05:48

Jafron Biomedical: Legal Opinion of Guohao Lawyers (Shenzhen) Firm on the Company's 2023 Annual General Meeting of Shareholders

May 20 05:48

Jafron Biomedical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 20 05:48

Jafron Biomedical: May 10, 2024 Investor Relations Activity Schedule

May 10 06:30

Jafron Biomedical: April 29, 2024 Investor Relations Activity Schedule

May 6 07:18

Jafron Biomedical: China Aviation Securities Co., Ltd.'s summary report on the continuous supervision and sponsorship of Jianfan Biotechnology Group Co., Ltd.'s issuance of convertible corporate bonds to unspecified targets

Apr 29 06:27

Jafron Biomedical: 2023 Annual Audit Report

Apr 25 11:00

Jafron Biomedical: Announcement on the determination of the 2023 remuneration of directors, supervisors and senior management and the 2024 remuneration plan

Apr 25 11:00

Jafron Biomedical: An indicative announcement on the disclosure of the report for the first quarter of 2024

Apr 25 11:00

Jafron Biomedical: 2023 Board Work Report

Apr 25 11:00

Jafron Biomedical: Notice on changes in accounting policies

Apr 25 11:00

Jafron Biomedical: 2023 Annual Report Summary

Apr 25 11:00

Jafron Biomedical: Special Instructions for Grant Thornton Accounting Firm (Special General Partnership) on the Company's Non-Operating Capital Occupation and Other Related Capital Transactions

Apr 25 11:00

Jafron Biomedical: Announcement on holding an online briefing on the 2023 annual results

Apr 25 11:00

Jafron Biomedical: Announcement on the repurchase and cancellation of some restricted shares

Apr 25 11:00

Jafron Biomedical: Legal Opinion of Guo Hao Lawyers (Shenzhen) Firm on matters relating to the repurchase and cancellation of some restricted stocks in the Company's 2021 Restricted Stock Incentive Plan

Apr 25 11:00